Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Congress is nearing an inflection point as President Donald Trump prepares to meet with Syrian President Ahmed al-Sharaa Monday.

Syria sanctions in the balance

Congress is nearing an inflection point as President Donald Trump prepares to meet with Syrian President Ahmed al-Sharaa Monday — and pressure builds to repeal sanctions against the country.

At issue is whether to fully repeal the Caesar Act sanctions, a move favored by key blocs within both parties.

“Giving the existing government in Syria the opportunity to prove itself as being seeking peace is a positive step,” Sen. Mike Rounds (R-S.D.) said.

The Trump administration has backed the repeal effort through the annual defense policy bill, with U.S. Special Envoy to Syria Tom Barrack and Secretary of State Marco Rubio among those making calls to lawmakers, according to multiple Hill sources.

A key holdout in the permanent repeal, according to people familiar with the matter, is House Foreign Affairs Committee Chair Brian Mast (R-Fla.). Mast’s office didn’t respond to a request for comment.

Trump said last week he’d temporarily waive sanctions “to give them a fighting shot, and I think [al-Sharaa’s] doing a very good job so far” but that “it’s a tough neighborhood and he’s a tough guy.” Permanently waiving the sanctions would require congressional action.

Sen. Richard Blumenthal (D-Conn.), a key foreign policy voice, said he favors peace “that can be pursued through specific and identifiable and enforceable conditions.”

Last week, the United Nations Security Council voted to remove al-Sharaa from a terrorism sanctions list just days ahead of his visit with Trump in a resolution championed by the United States.

“We must repeal Caesar sanctions so the Syrian people have a real chance at recovery after decades of dictatorship,” Sen. Jeanne Shaheen (D-N.H.), the top Foreign Relations Democrat, told Punchbowl News in a statement.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.